,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,3,22.1,Alopecia,16994920
0,6,22.1,Ascites,16994941
1,6,22.1,Inappropriate schedule of product administration,16994941
0,1,22.1,Pneumonia,16994950
1,1,22.1,Parainfluenzae virus infection,16994950
2,3,22.1,Constipation,16994950
3,1,22.1,Moraxella infection,16994950
4,3,22.1,Dyspnoea exertional,16994950
5,1,22.1,Hypokalaemia,16994950
6,3,22.1,Back pain,16994950
7,3,22.1,Stomatitis,16994950
8,1,22.1,Hyponatraemia,16994950
9,6,22.1,Asthenia,16994950
10,3,22.1,General physical health deterioration,16994950
11,3,22.1,Diarrhoea,16994950
12,3,22.1,Atrial fibrillation,16994950
13,1,22.1,Oedema peripheral,16994950
14,1,22.1,Diarrhoea,16994950
15,3,22.1,Proctalgia,16994950
16,1,22.1,Decreased appetite,16994950
17,1,22.1,Oral herpes,16994950
18,1,22.1,Pleural effusion,16994950
19,6,22.1,Fall,16994950
0,1,22.1,Pneumonia staphylococcal,16994955
0,2,22.1,Cyanosis,16994957
1,2,22.1,Rash,16994957
0,5,22.1,Hormone-refractory prostate cancer,16994976
0,2,22.1,Fatigue,16994977
1,1,22.1,Dehydration,16994977
2,2,22.1,Nephropathy toxic,16994977
3,2,22.1,Decreased appetite,16994977
0,6,22.1,Malignant neoplasm progression,16994989
1,5,22.1,Death,16994989
0,1,22.1,Decreased appetite,16994993
1,6,22.1,Haemorrhage subcutaneous,16994993
0,5,22.1,Death,16994999
0,5,22.1,Ascites,16995037
1,5,22.1,Liver disorder,16995037
0,3,22.1,Sleep disorder,16995051
1,3,22.1,Liver function test increased,16995051
2,1,22.1,Leukopenia,16995051
3,1,22.1,Liver function test abnormal,16995051
0,6,22.1,Malignant neoplasm progression,16995060
1,6,22.1,Drug ineffective,16995060
2,6,22.1,Pulmonary oedema,16995060
0,6,22.1,Coagulation test abnormal,16995075
1,1,22.1,Oedema peripheral,16995075
2,6,22.1,Malignant neoplasm progression,16995075
0,6,22.1,Neoplasm progression,16995102
0,1,22.1,White blood cell count decreased,16995104
0,5,22.1,Death,16995162
1,1,22.1,Anaemia,16995162
2,6,22.1,Disease recurrence,16995162
3,6,22.1,Prostate cancer recurrent,16995162
4,1,22.1,Thrombocytopenia,16995162
5,6,22.1,Drug ineffective,16995162
6,6,22.1,Prostate cancer,16995162
7,6,22.1,Disease progression,16995162
0,2,22.1,Albuminuria,16995169
1,6,22.1,Nephrotic syndrome,16995169
2,6,22.1,Bone marrow myelogram abnormal,16995169
3,6,22.1,Condition aggravated,16995169
4,6,22.1,Disease progression,16995169
5,6,22.1,Therapeutic response decreased,16995169
0,1,22.1,Anaphylactic shock,16995175
0,1,22.1,Intestinal obstruction,16995183
0,3,22.1,General physical health deterioration,16995198
1,4,22.1,Adrenocorticotropic hormone deficiency,16995198
0,6,22.1,Basal cell carcinoma,16995204
0,5,22.1,Death,16995219
0,6,22.1,Product use in unapproved indication,16995221
1,6,22.1,Neutropenia,16995221
2,6,22.1,Asthenia,16995221
0,6,22.1,Breast cancer metastatic,16995231
1,6,22.1,Malignant neoplasm progression,16995231
2,6,22.1,Hyperglycaemia,16995231
0,2,22.1,Erythema,16995235
1,3,22.1,Cough,16995235
2,1,22.1,Nausea,16995235
3,1,22.1,Vomiting,16995235
4,1,22.1,Diarrhoea,16995235
5,2,22.1,Erysipelas,16995235
6,3,22.1,Tumour marker increased,16995235
7,1,22.1,Chills,16995235
8,3,22.1,Poor quality sleep,16995235
9,3,22.1,Nausea,16995235
10,1,22.1,Vomiting,16995235
11,3,22.1,Pyrexia,16995235
12,3,22.1,Musculoskeletal pain,16995235
13,3,22.1,Dyspepsia,16995235
14,2,22.1,Swelling,16995235
15,6,22.1,Full blood count decreased,16995235
16,2,22.1,Pruritus,16995235
17,1,22.1,Abdominal pain,16995235
18,3,22.1,Nasopharyngitis,16995235
19,2,22.1,Neutrophil count decreased,16995235
0,5,22.1,Death,16995238
0,6,22.1,Drug resistance,16995241
1,6,22.1,Prostatic specific antigen increased,16995241
2,6,22.1,Fatigue,16995241
3,6,22.1,Malignant neoplasm progression,16995241
4,6,22.1,Drug ineffective,16995241
0,5,22.1,Death,16995271
0,5,22.1,Death,16995302
0,2,22.1,Toxicity to various agents,16995305
1,2,22.1,Thrombotic microangiopathy,16995305
2,6,22.1,Hypertension,16995305
3,2,22.1,Haemolytic anaemia,16995305
4,2,22.1,Proteinuria,16995305
5,2,22.1,Atypical haemolytic uraemic syndrome,16995305
6,2,22.1,Acute kidney injury,16995305
7,2,22.1,Normochromic anaemia,16995305
8,2,22.1,Thrombocytopenia,16995305
9,6,22.1,Asthenia,16995305
10,6,22.1,Decreased appetite,16995305
11,2,22.1,Thrombosis,16995305
12,2,22.1,Haematotoxicity,16995305
13,6,22.1,Oedema peripheral,16995305
14,6,22.1,Therapeutic response decreased,16995305
0,1,22.1,Syringe issue,16995332
1,1,22.1,Product administration error,16995332
2,3,22.1,Musculoskeletal chest pain,16995332
3,1,22.1,Intercepted medication error,16995332
4,,22.1,Extra dose administered,16995332
0,1,22.1,Febrile neutropenia,16995340
0,1,22.1,Hypogammaglobulinaemia,16995355
1,1,22.1,Opsoclonus myoclonus,16995355
2,1,22.1,Dysarthria,16995355
3,1,22.1,West Nile viral infection,16995355
4,1,22.1,Ocular discomfort,16995355
5,1,22.1,Myoclonus,16995355
0,3,22.1,Chronic kidney disease,16995378
0,1,22.1,Pancytopenia,16995391
1,1,22.1,Leukopenia,16995391
2,1,22.1,Thrombocytopenia,16995391
3,2,22.1,Anaemia,16995391
0,6,22.1,Diarrhoea,16995401
1,6,22.1,Product dose omission,16995401
2,6,22.1,Nausea,16995401
0,3,22.1,Madarosis,16995414
1,3,22.1,Hair colour changes,16995414
2,3,22.1,Hair texture abnormal,16995414
3,3,22.1,Hair disorder,16995414
4,3,22.1,Alopecia,16995414
5,6,22.1,Anxiety,16995414
0,6,22.1,Infection,16995427
0,6,22.1,Alopecia,16995441
1,6,22.1,Dyspnoea,16995441
2,6,22.1,Cough,16995441
0,6,22.1,Neoplasm progression,16995450
0,6,22.1,Liver function test increased,16995455
0,6,22.1,Alopecia,16995456
1,6,22.1,Vision blurred,16995456
2,6,22.1,Diarrhoea,16995456
3,2,22.1,Cough,16995456
4,6,22.1,Vomiting,16995456
5,2,22.1,Nasopharyngitis,16995456
6,6,22.1,Constipation,16995456
0,1,22.1,Nausea,16995461
1,4,22.1,Asthenia,16995461
2,1,22.1,Abdominal pain,16995461
3,1,22.1,Abdominal discomfort,16995461
4,4,22.1,Diarrhoea,16995461
0,6,22.1,Pain,16995462
1,6,22.1,Anxiety,16995462
2,6,22.1,Impaired quality of life,16995462
3,6,22.1,Emotional distress,16995462
4,6,22.1,Psychological trauma,16995462
5,3,22.1,Alopecia,16995462
0,2,22.1,Alopecia,16995475
1,6,22.1,Psychological trauma,16995475
0,5,22.1,Non-small cell lung cancer,16995477
1,5,22.1,Haemoptysis,16995477
0,6,22.1,Anxiety,16995497
1,6,22.1,Impaired quality of life,16995497
2,6,22.1,Pain,16995497
3,3,22.1,Alopecia,16995497
4,6,22.1,Emotional distress,16995497
5,6,22.1,Psychological trauma,16995497
0,6,22.1,Impaired quality of life,16995539
1,6,22.1,Pain,16995539
2,2,22.1,Alopecia,16995539
3,6,22.1,Anxiety,16995539
4,6,22.1,Emotional distress,16995539
0,6,22.1,Anxiety,16995550
1,6,22.1,Emotional distress,16995550
2,6,22.1,Impaired quality of life,16995550
3,2,22.1,Alopecia,16995550
4,6,22.1,Pain,16995550
0,2,22.1,Alopecia,16995565
1,6,22.1,Psychological trauma,16995565
0,6,22.1,Migraine,16995567
0,3,22.1,Alopecia,16995573
1,6,22.1,Psychological trauma,16995573
0,2,22.1,Alopecia,16995575
0,1,22.1,Urticaria,16995576
1,1,22.1,Diarrhoea,16995576
2,1,22.1,Nausea,16995576
3,1,22.1,Pruritus,16995576
0,6,22.1,Psychological trauma,16995593
1,2,22.1,Alopecia,16995593
0,6,22.1,Primary hypothyroidism,16995623
1,2,22.1,Fulminant type 1 diabetes mellitus,16995623
0,6,22.1,Hypotension,16995635
1,6,22.1,Hypertension,16995635
2,6,22.1,Vascular injury,16995635
3,6,22.1,Blood sodium decreased,16995635
4,6,22.1,Blood potassium decreased,16995635
0,5,22.1,Malignant neoplasm progression,16995644
1,1,22.1,Immune-mediated enterocolitis,16995644
2,6,22.1,Large intestine polyp,16995644
0,2,22.1,Adrenocorticotropic hormone deficiency,16995649
0,5,22.1,Hepatitis,16995691
0,,22.1,Needle issue,16995718
1,,22.1,Intercepted product preparation error,16995718
0,5,22.1,Neoplasm progression,16995727
0,3,22.1,Hair colour changes,16995732
1,3,22.1,Madarosis,16995732
2,3,22.1,Hair disorder,16995732
3,3,22.1,Alopecia,16995732
4,3,22.1,Hair texture abnormal,16995732
0,6,22.1,White blood cell count decreased,16995746
1,1,22.1,Abdominal discomfort,16995746
2,5,22.1,Death,16995746
0,6,22.1,Transaminases increased,16995766
1,6,22.1,Blood bilirubin increased,16995766
0,6,22.1,Hypothyroidism,16995812
0,1,22.1,Hypokalaemia,16995828
1,3,22.1,Diarrhoea,16995828
2,6,22.1,Blood calcium increased,16995828
3,3,22.1,Oedema peripheral,16995828
4,3,22.1,Vomiting,16995828
5,1,22.1,Lymphopenia,16995828
6,3,22.1,Nausea,16995828
7,1,22.1,Urinary tract infection,16995828
8,3,22.1,Blood creatinine increased,16995828
9,6,22.1,Depressed mood,16995828
10,1,22.1,Neutropenia,16995828
11,6,22.1,Depression,16995828
12,3,22.1,Fatigue,16995828
13,1,22.1,Viral infection,16995828
14,3,22.1,Pruritus,16995828
15,6,22.1,White blood cell count decreased,16995828
16,3,22.1,Anaemia,16995828
17,3,22.1,Electrocardiogram QT prolonged,16995828
18,1,22.1,Bronchitis,16995828
19,3,22.1,Intervertebral disc protrusion,16995828
0,3,22.1,Condition aggravated,16995835
1,3,22.1,Gamma-glutamyltransferase increased,16995835
2,1,22.1,Transaminases increased,16995835
0,5,22.1,Myocarditis,16995863
0,6,22.1,Insomnia,16995885
1,6,22.1,Headache,16995885
0,6,22.1,Diarrhoea,16995896
1,6,22.1,Fatigue,16995896
2,3,22.1,Neutrophil count decreased,16995896
0,6,22.1,Blood creatinine increased,16995898
1,6,22.1,Fatigue,16995898
0,1,22.1,White blood cell count decreased,16995906
0,3,22.1,Alopecia,16995912
1,3,22.1,Hair disorder,16995912
2,3,22.1,Hair texture abnormal,16995912
3,3,22.1,Hair colour changes,16995912
0,3,22.1,Confusional state,16995925
1,3,22.1,Memory impairment,16995925
2,6,22.1,Arthralgia,16995925
3,3,22.1,Diarrhoea,16995925
4,3,22.1,Pain,16995925
5,6,22.1,Haemoglobin decreased,16995925
6,1,22.1,Clostridium difficile infection,16995925
7,3,22.1,Weight decreased,16995925
8,6,22.1,Fatigue,16995925
9,6,22.1,Blood calcium increased,16995925
10,6,22.1,General physical health deterioration,16995925
0,4,22.1,Agitation,16995931
1,6,22.1,Urinary tract infection,16995931
2,6,22.1,Somnolence,16995931
3,5,22.1,Pneumonia,16995931
0,6,22.1,Lymphocyte count decreased,16995939
1,6,22.1,Gamma-glutamyltransferase increased,16995939
2,6,22.1,Aspartate aminotransferase increased,16995939
3,6,22.1,Alanine aminotransferase increased,16995939
4,6,22.1,Monocyte count increased,16995939
5,6,22.1,Metastases to liver,16995939
6,6,22.1,Malignant neoplasm progression,16995939
7,6,22.1,Carbohydrate antigen 15-3 increased,16995939
8,6,22.1,Haematocrit decreased,16995939
9,6,22.1,Breast cancer female,16995939
10,6,22.1,Blood glucose increased,16995939
11,6,22.1,Red blood cell count decreased,16995939
12,6,22.1,Red cell distribution width increased,16995939
0,3,22.1,Heart rate decreased,16995943
1,3,22.1,Drug ineffective,16995943
2,3,22.1,Platelet count decreased,16995943
3,3,22.1,Pain in extremity,16995943
4,3,22.1,Fatigue,16995943
5,3,22.1,Blood pressure diastolic decreased,16995943
6,3,22.1,Weight decreased,16995943
7,3,22.1,Dizziness,16995943
8,3,22.1,Musculoskeletal pain,16995943
9,3,22.1,Oxygen saturation decreased,16995943
10,3,22.1,Off label use,16995943
0,6,22.1,Blood thyroid stimulating hormone increased,16995949
1,6,22.1,Dysgeusia,16995949
2,6,22.1,Diarrhoea,16995949
0,5,22.1,Stevens-Johnson syndrome,16995969
0,3,22.1,Chest pain,16995972
1,3,22.1,Decreased appetite,16995972
2,5,22.1,Death,16995972
3,3,22.1,Dyspnoea,16995972
4,6,22.1,Neoplasm progression,16995972
5,3,22.1,Joint swelling,16995972
6,3,22.1,Dyspepsia,16995972
7,3,22.1,Diarrhoea,16995972
8,6,22.1,Abdominal discomfort,16995972
9,3,22.1,Fungal infection,16995972
10,1,22.1,Blood pressure increased,16995972
11,1,22.1,Hordeolum,16995972
12,6,22.1,Oesophageal ulcer,16995972
13,3,22.1,Odynophagia,16995972
14,3,22.1,Oral discomfort,16995972
15,1,22.1,Nausea,16995972
16,3,22.1,Glossodynia,16995972
0,2,22.1,Dermatomyositis,16995976
1,6,22.1,Epididymitis,16995976
2,6,22.1,Eczema,16995976
0,2,22.1,Myalgia,16995987
1,2,22.1,Arthralgia,16995987
0,6,22.1,Neutropenia,16996005
1,6,22.1,Blood creatinine increased,16996005
0,6,22.1,White blood cell count decreased,16996018
0,3,22.1,Hair disorder,16996056
1,3,22.1,Madarosis,16996056
2,3,22.1,Hair texture abnormal,16996056
3,3,22.1,Alopecia,16996056
4,3,22.1,Hair colour changes,16996056
5,6,22.1,Depression,16996056
0,5,22.1,Endocarditis,16996131
1,1,22.1,Gastrointestinal inflammation,16996131
0,1,22.1,Bundle branch block left,16996143
1,1,22.1,Electrocardiogram QT prolonged,16996143
0,6,22.1,Product availability issue,16996178
1,6,22.1,No adverse event,16996178
2,6,22.1,Product dose omission,16996178
0,1,22.1,Dizziness,16996179
1,6,22.1,Atelectasis,16996179
0,2,22.1,Platelet count decreased,16996185
0,3,22.1,Gastric perforation,16996214
1,6,22.1,Neutrophil count decreased,16996214
2,6,22.1,Peritonitis,16996214
0,6,22.1,White blood cell count decreased,16996289
1,6,22.1,Dizziness,16996289
2,6,22.1,Haematocrit decreased,16996289
3,6,22.1,Abdominal pain upper,16996289
4,6,22.1,Red blood cell count decreased,16996289
0,5,22.1,Death,16996315
1,6,22.1,Pneumonia,16996315
0,3,22.1,Nausea,16996316
1,3,22.1,Myalgia,16996316
2,2,22.1,Vomiting,16996316
3,6,22.1,Hypertension,16996316
4,3,22.1,Decreased appetite,16996316
5,6,22.1,Pain,16996316
6,2,22.1,Dehydration,16996316
7,3,22.1,Abdominal pain,16996316
8,3,22.1,Asthenia,16996316
0,5,22.1,Death,16996329
0,5,22.1,Neoplasm progression,16996341
0,6,22.1,Neutropenia,16996351
0,6,22.1,Thrombosis,16996368
0,6,22.1,Cholangitis,16996370
0,6,22.1,Abdominal pain upper,16996379
0,5,22.1,Tumour hyperprogression,16996414
1,6,22.1,Immune-mediated adverse reaction,16996414
0,6,22.1,Malignant neoplasm progression,16996444
0,1,22.1,Fatigue,16996484
1,3,22.1,Jaw fistula,16996484
2,1,22.1,Dizziness,16996484
3,6,22.1,Back pain,16996484
0,3,22.1,Malignant neoplasm progression,16996522
1,3,22.1,Renal cancer,16996522
0,1,22.1,Dyspnoea,16996531
1,1,22.1,Throat tightness,16996531
2,1,22.1,Laryngospasm,16996531
0,6,22.1,Drug interaction,16996622
1,6,22.1,Underdose,16996622
0,1,22.1,Malaise,16996655
1,1,22.1,Fall,16996655
0,6,22.1,General physical health deterioration,16996716
1,3,22.1,Limb discomfort,16996716
2,6,22.1,Erythema,16996716
3,3,22.1,Mobility decreased,16996716
4,6,22.1,Gait disturbance,16996716
5,6,22.1,Headache,16996716
6,6,22.1,Metastases to peripheral nervous system,16996716
7,6,22.1,Muscle atrophy,16996716
8,6,22.1,Pain in extremity,16996716
9,3,22.1,Peripheral swelling,16996716
10,1,22.1,Thrombosis,16996716
11,6,22.1,Limb deformity,16996716
0,5,22.1,Febrile neutropenia,16996725
0,5,22.1,Death,16996886
0,6,22.1,Myocardial infarction,16996887
0,6,22.1,Drug interaction,16996898
1,6,22.1,Product prescribing error,16996898
2,6,22.1,Depression,16996898
0,1,22.1,Hypotension,16996900
1,1,22.1,Dyspnoea,16996900
2,1,22.1,Urticaria,16996900
3,1,22.1,Flushing,16996900
4,1,22.1,Type I hypersensitivity,16996900
5,1,22.1,Chest discomfort,16996900
6,1,22.1,Hypertension,16996900
0,3,22.1,Visual field defect,16996940
1,3,22.1,Vision blurred,16996940
0,2,22.1,Cyanosis,16996994
1,2,22.1,Rash,16996994
0,,22.1,Ulcer haemorrhage,16997049
0,6,22.1,Cholecystitis acute,16997053
1,6,22.1,Tachycardia,16997053
2,6,22.1,Abdominal pain,16997053
3,1,22.1,Wound infection,16997053
4,6,22.1,Syncope,16997053
5,6,22.1,Pyrexia,16997053
0,6,22.1,Bile duct stenosis,16997170
1,6,22.1,Cholangitis,16997170
0,1,22.1,Cerebrovascular accident,16997192
0,6,22.1,Off label use,16997219
1,6,22.1,Device leakage,16997219
2,6,22.1,Drug delivery system malfunction,16997219
0,6,22.1,Pneumonitis,16997229
1,6,22.1,Haemoptysis,16997229
2,6,22.1,Bronchial fistula,16997229
0,1,22.1,Diarrhoea,16997269
1,1,22.1,Dehydration,16997269
2,1,22.1,Infection,16997269
3,3,22.1,Vomiting,16997269
0,3,22.1,Infection,16997321
1,3,22.1,Dehydration,16997321
2,5,22.1,Death,16997321
0,6,22.1,Ascites,16997335
1,6,22.1,Diabetes mellitus,16997335
2,6,22.1,Hypertension,16997335
0,3,22.1,Blood creatine phosphokinase increased,16997456
0,2,22.1,Prostate cancer,16997478
1,2,22.1,Drug interaction,16997478
2,2,22.1,Drug level decreased,16997478
3,2,22.1,Drug ineffective,16997478
0,1,22.1,Herpes zoster,16997491
0,3,22.1,Anaphylactic shock,16997502
0,1,22.1,Melaena,16997571
1,1,22.1,Upper gastrointestinal haemorrhage,16997571
2,3,22.1,Chronic obstructive pulmonary disease,16997571
3,1,22.1,Haemoglobin decreased,16997571
4,1,22.1,Thrombocytopenia,16997571
5,1,22.1,Angiodysplasia,16997571
6,3,22.1,Lymphoedema,16997571
7,1,22.1,Leukopenia,16997571
0,2,22.1,Interstitial lung disease,16997608
1,1,22.1,Malaise,16997608
0,6,22.1,Off label use,16997692
1,6,22.1,No adverse event,16997692
2,6,22.1,Therapeutic product effect decreased,16997692
3,3,22.1,Disease progression,16997692
0,3,22.1,Radiation pneumonitis,16997706
0,5,22.1,Death,16997728
0,2,22.1,Thrombocytopenia,16997754
1,2,22.1,Rash,16997754
2,2,22.1,Thrombocytosis,16997754
3,2,22.1,Abdominal pain upper,16997754
4,2,22.1,Musculoskeletal pain,16997754
5,2,22.1,Oral discomfort,16997754
6,2,22.1,Lip swelling,16997754
7,2,22.1,Erythema,16997754
8,3,22.1,Flank pain,16997754
0,1,22.1,Throat tightness,16997768
1,1,22.1,Hypertension,16997768
2,1,22.1,Dysphonia,16997768
3,1,22.1,Hyperhidrosis,16997768
0,2,22.1,Enteritis,16997785
0,,22.1,Death,16997828
0,,22.1,Musculoskeletal stiffness,16997835
1,,22.1,Pulse abnormal,16997835
2,,22.1,Cardio-respiratory arrest,16997835
3,,22.1,Unresponsive to stimuli,16997835
0,3,22.1,Fatigue,16997980
1,3,22.1,Stress,16997980
2,3,22.1,Gastrointestinal disorder,16997980
3,3,22.1,Diarrhoea,16997980
4,2,22.1,White blood cell count decreased,16997980
5,6,22.1,Platelet count decreased,16997980
0,6,22.1,Ageusia,16998059
1,1,22.1,Nausea,16998059
2,1,22.1,Vomiting,16998059
0,,22.1,Muscle spasms,16998084
0,1,22.1,Pyrexia,16998086
1,1,22.1,Chills,16998086
0,,22.1,Pain,16998088
1,,22.1,Gait inability,16998088
2,,22.1,Drug ineffective,16998088
3,,22.1,Nausea,16998088
4,,22.1,Malignant neoplasm progression,16998088
0,1,22.1,Pulmonary embolism,16998094
0,6,22.1,Neutrophil count decreased,16998129
1,6,22.1,Inappropriate antidiuretic hormone secretion,16998129
0,1,22.1,Dyspnoea,16998149
1,1,22.1,Throat tightness,16998149
2,1,22.1,Laryngospasm,16998149
0,1,22.1,Dyspepsia,16998204
1,1,22.1,Nausea,16998204
2,1,22.1,Ill-defined disorder,16998204
3,3,22.1,Carbohydrate antigen 125 increased,16998204
4,6,22.1,Weight decreased,16998204
5,3,22.1,Constipation,16998204
6,6,22.1,Urinary retention,16998204
7,3,22.1,Fatigue,16998204
8,6,22.1,Vomiting,16998204
9,6,22.1,Decreased appetite,16998204
10,1,22.1,Feeding disorder,16998204
0,6,22.1,Product use in unapproved indication,16998209
1,6,22.1,Haematocrit decreased,16998209
2,6,22.1,Haemoglobin decreased,16998209
3,6,22.1,Myelodysplastic syndrome,16998209
0,6,22.1,Insomnia,16998215
1,6,22.1,Vomiting,16998215
2,6,22.1,Dyspnoea,16998215
3,6,22.1,Fatigue,16998215
4,6,22.1,Bone marrow failure,16998215
5,1,22.1,Anaemia,16998215
6,3,22.1,Nausea,16998215
7,6,22.1,Cough,16998215
0,6,22.1,Jaundice,16998271
0,2,22.1,Eyelid exfoliation,16998349
1,2,22.1,Rash,16998349
0,6,22.1,Demyelinating polyneuropathy,16998387
0,2,22.1,Immune-mediated neuropathy,16998396
0,1,22.1,Herpes zoster,16998437
0,5,22.1,Haemorrhagic stroke,16998537
0,2,22.1,Cutaneous lupus erythematosus,16998556
0,6,22.1,Thrombosis,16998568
1,6,22.1,Blood pressure increased,16998568
2,6,22.1,Weight decreased,16998568
3,1,22.1,Thyroid hormones increased,16998568
4,6,22.1,Palpitations,16998568
5,6,22.1,Influenza,16998568
0,,22.1,Sluggishness,16998575
1,,22.1,Pain,16998575
2,,22.1,Nasopharyngitis,16998575
0,,22.1,Haemoglobin decreased,16998594
0,6,22.1,Positron emission tomogram abnormal,16998610
1,3,22.1,Dry mouth,16998610
2,6,22.1,Recurrent cancer,16998610
3,6,22.1,Rash,16998610
4,6,22.1,Photosensitivity reaction,16998610
5,3,22.1,Carbohydrate antigen 125 increased,16998610
0,,22.1,Death,16998615
0,,22.1,Death,16998628
0,,22.1,Haemorrhage,16998633
1,,22.1,Disease progression,16998633
0,1,22.1,Non-cardiac chest pain,16998638
1,1,22.1,Flushing,16998638
2,1,22.1,Back pain,16998638
3,1,22.1,Tachycardia,16998638
4,1,22.1,Dyspnoea,16998638
5,1,22.1,Type I hypersensitivity,16998638
6,1,22.1,Paraesthesia,16998638
0,,22.1,Nausea,16998639
1,,22.1,Fatigue,16998639
0,6,22.1,Cholestasis,16998739
0,6,22.1,Metastases to bone,16998756
1,5,22.1,Death,16998756
2,6,22.1,Metastases to lung,16998756
0,6,22.1,Dysphagia,16998796
1,6,22.1,Rash,16998796
0,1,22.1,Skin ulcer,16998801
0,2,22.1,Drug ineffective,16998843
0,6,22.1,Neuropathy peripheral,16998937
1,6,22.1,Syncope,16998937
2,6,22.1,Bradycardia,16998937
0,6,22.1,Androgen deficiency,16999016
1,6,22.1,Lumbosacral radiculopathy,16999016
2,3,22.1,Psoriatic arthropathy,16999016
3,6,22.1,Pulmonary mass,16999016
0,2,22.1,Fall,16999020
1,3,22.1,Musculoskeletal stiffness,16999020
2,3,22.1,Feeling abnormal,16999020
3,2,22.1,Weight decreased,16999020
4,3,22.1,Hypersomnia,16999020
5,3,22.1,Depressed mood,16999020
6,2,22.1,Insomnia,16999020
7,2,22.1,Immobile,16999020
8,2,22.1,Dyspnoea,16999020
9,2,22.1,Influenza,16999020
10,3,22.1,Abdominal pain upper,16999020
11,3,22.1,Eating disorder,16999020
0,5,22.1,Death,16999048
0,6,22.1,Depression,16999089
1,6,22.1,Product prescribing error,16999089
2,6,22.1,Drug interaction,16999089
0,,22.1,Cerebrovascular accident,16999147
0,,22.1,Syringe issue,16999331
1,,22.1,Intercepted product preparation error,16999331
2,,22.1,Wrong technique in product usage process,16999331
3,,22.1,Device leakage,16999331
0,,22.1,Acute respiratory distress syndrome,16999339
0,5,22.1,Cerebral haemorrhage,16999350
0,5,22.1,Death,16999351
0,5,22.1,Death,16999354
0,5,22.1,Death,16999358
0,5,22.1,Death,16999377
0,1,22.1,Intestinal perforation,16999380
1,5,22.1,Ileus paralytic,16999380
2,5,22.1,Bone marrow failure,16999380
3,5,22.1,Hypotension,16999380
0,5,22.1,Death,16999406
1,1,22.1,Pneumonitis,16999406
0,6,22.1,Muscle spasms,16999421
1,6,22.1,Neutropenia,16999421
2,6,22.1,Lip erythema,16999421
3,6,22.1,Headache,16999421
4,6,22.1,Lip exfoliation,16999421
5,6,22.1,Fatigue,16999421
0,6,22.1,White blood cell count decreased,16999423
0,6,22.1,Hypoacusis,16999440
0,6,22.1,Injury,16999441
1,6,22.1,Metastases to lung,16999441
2,2,22.1,Influenza,16999441
3,6,22.1,Pneumonia,16999441
4,6,22.1,Cough,16999441
5,6,22.1,Back pain,16999441
6,6,22.1,General physical condition abnormal,16999441
7,6,22.1,White blood cell count decreased,16999441
8,6,22.1,Apparent death,16999441
9,6,22.1,Decreased immune responsiveness,16999441
10,6,22.1,Neutrophil count decreased,16999441
11,6,22.1,Drug ineffective,16999441
0,6,22.1,Fatigue,16999461
0,3,22.1,Alopecia,16999466
0,3,22.1,Hair texture abnormal,16999487
1,3,22.1,Alopecia,16999487
2,3,22.1,Hair disorder,16999487
3,3,22.1,Hair colour changes,16999487
4,3,22.1,Madarosis,16999487
0,3,22.1,Hair texture abnormal,16999496
1,3,22.1,Hair disorder,16999496
2,3,22.1,Hair colour changes,16999496
3,3,22.1,Alopecia,16999496
0,6,22.1,Adverse event,16999508
0,3,22.1,Type 1 diabetes mellitus,16999525
1,3,22.1,Adrenocorticotropic hormone deficiency,16999525
0,,22.1,Fall,16999562
1,,22.1,Hip fracture,16999562
0,1,22.1,Cytopenia,16999568
0,2,22.1,Loss of consciousness,16999570
1,2,22.1,Ventricular tachycardia,16999570
2,1,22.1,Subcutaneous haematoma,16999570
0,1,22.1,Loss of consciousness,16999579
1,1,22.1,Blood glucose fluctuation,16999579
0,6,22.1,Intervertebral disc protrusion,16999580
1,6,22.1,Arthralgia,16999580
2,6,22.1,Feeling abnormal,16999580
3,6,22.1,Memory impairment,16999580
4,6,22.1,Back pain,16999580
5,6,22.1,Nasopharyngitis,16999580
6,6,22.1,Spinal cord neoplasm,16999580
7,6,22.1,Breast mass,16999580
8,6,22.1,Breast cancer stage IV,16999580
9,6,22.1,Insomnia,16999580
10,6,22.1,Pruritus,16999580
11,6,22.1,Hot flush,16999580
12,6,22.1,Stress,16999580
0,2,22.1,Cholangitis,16999610
0,2,22.1,Cholangitis,16999612
0,6,22.1,Drug-induced liver injury,16999627
1,6,22.1,Malignant neoplasm progression,16999627
2,6,22.1,Disseminated intravascular coagulation,16999627
0,3,22.1,Bone pain,16999637
1,6,22.1,Liver disorder,16999637
2,3,22.1,Joint range of motion decreased,16999637
3,6,22.1,Gastritis,16999637
4,6,22.1,Diabetes mellitus,16999637
5,3,22.1,Spinal pain,16999637
0,1,22.1,Delirium,16999647
0,2,22.1,IgA nephropathy,16999648
1,2,22.1,Tubulointerstitial nephritis,16999648
2,3,22.1,Renal impairment,16999648
0,6,22.1,Cholangitis,16999652
0,1,22.1,Anaemia,16999653
0,6,22.1,Metastases to liver,16999667
1,6,22.1,Breast cancer,16999667
2,6,22.1,Malignant neoplasm progression,16999667
3,6,22.1,Metastases to the mediastinum,16999667
0,,22.1,Haemoptysis,16999701
1,,22.1,Pneumonitis,16999701
2,,22.1,Respiratory failure,16999701
0,6,22.1,Lipodystrophy acquired,16999711
0,2,22.1,Gait inability,16999722
1,2,22.1,Fall,16999722
2,2,22.1,Arthralgia,16999722
3,2,22.1,Phlebitis,16999722
4,2,22.1,Spondylitis,16999722
5,2,22.1,Osteoarthritis,16999722
0,6,22.1,Neoplasm progression,16999734
0,1,22.1,Foetal exposure during pregnancy,16999751
1,2,22.1,Atrial septal defect,16999751
0,5,22.1,Pneumonia,16999753
0,5,22.1,Pneumonia aspiration,16999776
1,6,22.1,Leukoencephalopathy,16999776
2,6,22.1,Upper motor neurone lesion,16999776
0,6,22.1,Cardiac failure,16999805
0,5,22.1,Death,16999838
0,1,22.1,Colitis,16999909
1,1,22.1,Acute kidney injury,16999909
0,5,22.1,Interstitial lung disease,16999918
1,5,22.1,Respiratory distress,16999918
0,6,22.1,Functional gastrointestinal disorder,16999962
0,5,22.1,Death,16999963
0,1,22.1,Infusion related reaction,16999973
1,1,22.1,Flushing,16999973
2,1,22.1,Abdominal pain,16999973
3,1,22.1,Dyspnoea,16999973
0,5,22.1,Intestinal perforation,16999974
1,6,22.1,Malaise,16999974
2,6,22.1,Neutrophil count decreased,16999974
0,1,22.1,Hypotension,16999994
1,1,22.1,Hypersensitivity,16999994
2,1,22.1,Loss of consciousness,16999994
3,1,22.1,Oxygen saturation decreased,16999994
0,5,22.1,Respiratory failure,17000009
1,5,22.1,Febrile neutropenia,17000009
2,5,22.1,Pneumonitis,17000009
3,5,22.1,Pneumonia,17000009
0,6,22.1,Pulmonary embolism,17000011
0,1,22.1,Loss of consciousness,17000033
1,1,22.1,Hypotension,17000033
2,1,22.1,Hypersensitivity,17000033
3,1,22.1,Oxygen saturation decreased,17000033
0,6,22.1,Dyspnoea,17000035
1,6,22.1,Acute interstitial pneumonitis,17000035
0,1,22.1,Wheezing,17000037
1,1,22.1,Flushing,17000037
2,1,22.1,Unresponsive to stimuli,17000037
3,1,22.1,Blood pressure abnormal,17000037
4,1,22.1,Focal dyscognitive seizures,17000037
5,1,22.1,Respiratory arrest,17000037
6,1,22.1,Heart rate decreased,17000037
0,6,22.1,Back pain,17000103
1,1,22.1,Kidney infection,17000103
0,6,22.1,Multiple-drug resistance,17000115
1,6,22.1,Off label use,17000115
0,1,22.1,Sepsis,17000125
1,1,22.1,Urinary tract infection,17000125
0,1,22.1,Transfusion,17000128
0,1,22.1,Gastrointestinal haemorrhage,17000136
0,6,22.1,Myocardial infarction,17000141
0,6,22.1,Hepatic calcification,17000149
1,6,22.1,Off label use,17000149
2,6,22.1,Multiple-drug resistance,17000149
0,6,22.1,Multiple-drug resistance,17000160
1,6,22.1,Off label use,17000160
0,3,22.1,Blood pressure increased,17000164
1,3,22.1,Back pain,17000164
2,3,22.1,Dyspnoea,17000164
3,3,22.1,Chest pain,17000164
4,3,22.1,Oxygen saturation decreased,17000164
0,5,22.1,Haemoptysis,17000175
1,5,22.1,Malignant neoplasm progression,17000175
0,2,22.1,Platelet count increased,17000183
1,2,22.1,Blood creatinine increased,17000183
2,6,22.1,Dehydration,17000183
3,2,22.1,Haematocrit decreased,17000183
4,2,22.1,Blood potassium increased,17000183
5,6,22.1,Dyspnoea,17000183
6,2,22.1,Red blood cell count decreased,17000183
7,2,22.1,Fatigue,17000183
8,6,22.1,Acute kidney injury,17000183
9,2,22.1,Blood magnesium increased,17000183
10,2,22.1,Blood sodium decreased,17000183
11,2,22.1,Haemoglobin decreased,17000183
12,1,22.1,Neutropenia,17000183
13,6,22.1,Intentional dose omission,17000183
0,5,22.1,Death,17000197
1,5,22.1,Acute hepatic failure,17000197
2,5,22.1,Hepatitis B reactivation,17000197
0,6,22.1,Haemorrhage,17000198
0,6,22.1,Dyspnoea,17000208
1,6,22.1,Flushing,17000208
2,6,22.1,Anxiety,17000208
3,6,22.1,Chest pain,17000208
0,5,22.1,Death,17000219
0,5,22.1,Febrile neutropenia,17000228
1,5,22.1,Barotrauma,17000228
2,5,22.1,Pleural effusion,17000228
3,5,22.1,Septic shock,17000228
4,5,22.1,Neutrophil count,17000228
5,5,22.1,Diffuse alveolar damage,17000228
6,5,22.1,Respiratory failure,17000228
0,1,22.1,Urosepsis,17000244
1,2,22.1,Pancytopenia,17000244
2,1,22.1,Anaemia,17000244
3,1,22.1,Urosepsis,17000244
4,1,22.1,Renal impairment,17000244
5,1,22.1,Tachycardia,17000244
6,1,22.1,Renal disorder,17000244
0,3,22.1,Neoplasm progression,17000246
1,3,22.1,Ascites,17000246
0,5,22.1,Death,17000248
0,6,22.1,Pathological fracture,17000249
1,6,22.1,Erythema,17000249
0,6,22.1,Anaemia,17000250
1,6,22.1,Constipation,17000250
2,3,22.1,Interstitial lung disease,17000250
3,3,22.1,Pneumonitis,17000250
4,6,22.1,White blood cell count decreased,17000250
5,6,22.1,Fatigue,17000250
6,3,22.1,Dyspnoea,17000250
7,3,22.1,Pancytopenia,17000250
8,6,22.1,Red blood cell count decreased,17000250
9,6,22.1,Alopecia,17000250
0,3,22.1,Blood pressure abnormal,17000297
1,3,22.1,Heart rate irregular,17000297
2,3,22.1,Neoplasm progression,17000297
3,3,22.1,Blood pressure increased,17000297
4,3,22.1,Heart rate increased,17000297
0,5,22.1,Hypoxia,17000306
1,5,22.1,Death,17000306
2,5,22.1,Pleural effusion,17000306
3,5,22.1,Pericardial effusion,17000306
4,5,22.1,Malignant pleural effusion,17000306
0,5,22.1,Death,17000310
0,1,22.1,Febrile neutropenia,17000317
1,1,22.1,Anaemia,17000317
2,1,22.1,Diarrhoea,17000317
0,6,22.1,Neuropathy peripheral,17000318
1,6,22.1,Neoplasm progression,17000318
0,6,22.1,Malignant neoplasm progression,17000333
0,3,22.1,Arthralgia,17000340
1,3,22.1,Pancreatitis,17000340
2,3,22.1,Hypertension,17000340
3,3,22.1,Fatigue,17000340
4,3,22.1,Ageusia,17000340
0,6,22.1,Kidney infection,17000365
1,6,22.1,Pain,17000365
0,5,22.1,Death,17000371
0,1,22.1,Neutropenia,17000384
1,2,22.1,Renal failure,17000384
0,6,22.1,Tumour rupture,17000387
1,6,22.1,Metastatic neoplasm,17000387
2,6,22.1,Drug ineffective,17000387
0,6,22.1,Weight increased,17000390
1,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,17000390
2,6,22.1,Malignant neoplasm progression,17000390
3,6,22.1,Skin toxicity,17000390
4,6,22.1,Mucosal inflammation,17000390
5,6,22.1,Neutropenia,17000390
0,6,22.1,Product dispensing error,17000402
1,6,22.1,Infection,17000402
2,6,22.1,Mass,17000402
0,5,22.1,Acute myeloid leukaemia,17000403
1,5,22.1,Haematoma,17000403
2,5,22.1,Fall,17000403
3,6,22.1,Infection,17000403
4,6,22.1,Back pain,17000403
0,3,22.1,Visual impairment,17000405
1,3,22.1,Papilloedema,17000405
2,6,22.1,Malignant neoplasm progression,17000405
3,3,22.1,Vision blurred,17000405
0,1,22.1,Gastroenteritis,17000407
1,1,22.1,Acute kidney injury,17000407
0,3,22.1,Skin exfoliation,17000425
1,3,22.1,Urticaria,17000425
2,3,22.1,Swollen tongue,17000425
3,3,22.1,Pharyngeal swelling,17000425
4,3,22.1,Anaemia,17000425
0,3,22.1,Rhabdomyolysis,17000436
1,6,22.1,Dehydration,17000436
2,6,22.1,Decreased appetite,17000436
0,6,22.1,Pleural effusion,17000445
1,6,22.1,Malignant neoplasm progression,17000445
2,6,22.1,Polyneuropathy,17000445
3,6,22.1,Off label use,17000445
4,6,22.1,Dyspnoea,17000445
0,6,22.1,Off label use,17000449
1,5,22.1,Death,17000449
0,1,22.1,Hepatitis,17000472
0,1,22.1,Cerebrovascular accident,17000487
0,6,22.1,Cardiomyopathy,17000497
1,6,22.1,Fatigue,17000497
0,3,22.1,Muscle disorder,17000503
1,3,22.1,Blood testosterone decreased,17000503
2,3,22.1,Muscular weakness,17000503
3,6,22.1,Post procedural complication,17000503
4,6,22.1,Gallbladder disorder,17000503
5,6,22.1,Gait disturbance,17000503
6,6,22.1,Prostatic disorder,17000503
0,2,22.1,Lumbar vertebral fracture,17000535
1,1,22.1,Fall,17000535
0,3,22.1,Dyspnoea,17000541
1,1,22.1,Hot flush,17000541
2,1,22.1,Muscle spasms,17000541
0,3,22.1,Vomiting,17000563
0,6,22.1,Arthralgia,17000564
0,6,22.1,Metastases to central nervous system,17000565
1,5,22.1,Death,17000565
2,6,22.1,Diarrhoea,17000565
3,6,22.1,Nail toxicity,17000565
4,6,22.1,Skin toxicity,17000565
5,6,22.1,Peripheral artery occlusion,17000565
6,6,22.1,Proteinuria,17000565
7,6,22.1,Neuropathy peripheral,17000565
8,6,22.1,Brain oedema,17000565
9,6,22.1,Malignant neoplasm progression,17000565
0,6,22.1,Cytopenia,17000574
1,5,22.1,Myocardial infarction,17000574
0,3,22.1,Metastases to liver,17000581
1,3,22.1,Breast cancer,17000581
2,3,22.1,Dyspnoea,17000581
3,3,22.1,Malignant neoplasm progression,17000581
4,3,22.1,Pleural effusion,17000581
0,6,22.1,Rebound effect,17000588
1,6,22.1,Myocarditis,17000588
0,6,22.1,Metastases to liver,17000670
1,6,22.1,Metastases to peritoneum,17000670
2,6,22.1,Malignant ascites,17000670
0,3,22.1,Tumour marker increased,17000708
1,3,22.1,Hypertension,17000708
2,2,22.1,Back pain,17000708
3,3,22.1,Diabetes mellitus,17000708
0,1,22.1,Myocardial infarction,17000753
1,1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17000753
0,5,22.1,Septic shock,17000754
0,5,22.1,Death,17000764
0,6,22.1,Cyanosis,17000771
1,6,22.1,Off label use,17000771
2,6,22.1,Dysphagia,17000771
3,6,22.1,Dyspnoea,17000771
4,6,22.1,Loss of consciousness,17000771
0,6,22.1,Delirium,17000811
1,6,22.1,Motor dysfunction,17000811
0,5,22.1,Febrile neutropenia,17000815
0,2,22.1,Bronchopulmonary aspergillosis,17000845
0,,22.1,Cholangitis sclerosing,17000875
1,,22.1,Inappropriate antidiuretic hormone secretion,17000875
2,5,22.1,Malignant neoplasm progression,17000875
3,,22.1,Rash,17000875
4,,22.1,Urinary tract infection,17000875
5,2,22.1,Cholangitis,17000875
6,,22.1,Lymphadenopathy,17000875
0,6,22.1,Metastasis,17000889
1,6,22.1,Dysphagia,17000889
0,2,22.1,Hypercholesterolaemia,17000928
1,6,22.1,Mucosal inflammation,17000928
2,6,22.1,Asthenia,17000928
3,6,22.1,Petechiae,17000928
4,6,22.1,Depressed mood,17000928
5,6,22.1,Blood creatinine increased,17000928
6,6,22.1,Electrocardiogram QT prolonged,17000928
0,2,22.1,Radiation pneumonitis,17000953
0,5,22.1,Neutropenic sepsis,17001010
0,5,22.1,Death,17001044
0,6,22.1,Anxiety,17001099
1,2,22.1,Alopecia,17001099
2,6,22.1,Pain,17001099
3,6,22.1,Psychological trauma,17001099
4,6,22.1,Emotional distress,17001099
5,6,22.1,Impaired quality of life,17001099
0,2,22.1,Alopecia,17001111
1,6,22.1,Pain,17001111
2,6,22.1,Psychological trauma,17001111
3,6,22.1,Emotional distress,17001111
4,6,22.1,Anxiety,17001111
5,6,22.1,Impaired quality of life,17001111
0,1,22.1,Cellulitis,17001127
0,3,22.1,Asthenia,17001153
1,6,22.1,Drug ineffective,17001153
2,5,22.1,Neoplasm malignant,17001153
3,6,22.1,Pain,17001153
0,6,22.1,Malignant neoplasm progression,17001165
1,6,22.1,Drug resistance,17001165
0,3,22.1,Alopecia,17001244
0,6,22.1,Tooth infection,17001270
1,6,22.1,Red blood cell count decreased,17001270
2,6,22.1,Blood count abnormal,17001270
3,6,22.1,White blood cell count decreased,17001270
0,,22.1,Intercepted product preparation error,17001289
1,,22.1,Device leakage,17001289
2,,22.1,Wrong technique in product usage process,17001289
0,1,22.1,Rash maculo-papular,17001377
1,1,22.1,Mucosal inflammation,17001377
0,1,22.1,Malaise,17001383
0,6,22.1,Fatigue,17001385
1,6,22.1,Alopecia,17001385
0,2,22.1,Mucosal inflammation,17001397
1,2,22.1,Palmar-plantar erythrodysaesthesia syndrome,17001397
2,3,22.1,Neuropathy peripheral,17001397
0,3,22.1,Fine motor skill dysfunction,17001402
1,3,22.1,Neuropathy peripheral,17001402
2,6,22.1,Impaired work ability,17001402
3,3,22.1,Paraesthesia,17001402
4,3,22.1,Pain in extremity,17001402
5,3,22.1,Muscular weakness,17001402
0,6,22.1,Fatigue,17001407
1,6,22.1,Abdominal pain upper,17001407
0,4,22.1,Neoplasm progression,17001446
0,1,22.1,Prostatitis,17001476
1,1,22.1,Alanine aminotransferase increased,17001476
2,5,22.1,Interstitial lung disease,17001476
3,1,22.1,Aspartate aminotransferase increased,17001476
4,1,22.1,Immune-mediated enterocolitis,17001476
0,2,22.1,Urinary tract infection,17001478
0,2,22.1,Pulmonary embolism,17001480
0,1,22.1,Decreased appetite,17001494
1,1,22.1,Pneumonia,17001494
2,1,22.1,Chronic obstructive pulmonary disease,17001494
0,1,22.1,Hyperhidrosis,17001497
1,1,22.1,Vomiting,17001497
2,1,22.1,Malaise,17001497
3,4,22.1,Acute coronary syndrome,17001497
0,6,22.1,Hypercalcaemia,17001502
0,6,22.1,Discomfort,17001521
1,6,22.1,Back pain,17001521
2,6,22.1,Hot flush,17001521
3,6,22.1,Fall,17001521
4,6,22.1,Agitation,17001521
5,6,22.1,Limb injury,17001521
6,6,22.1,Back injury,17001521
7,6,22.1,Presyncope,17001521
0,3,22.1,Haemorrhage intracranial,17001525
1,3,22.1,Spinal cord compression,17001525
2,6,22.1,Prostate cancer,17001525
0,1,22.1,Nausea,17001539
1,1,22.1,Drug eruption,17001539
2,5,22.1,Interstitial lung disease,17001539
3,6,22.1,Heat illness,17001539
4,6,22.1,Aspiration,17001539
5,1,22.1,Hepatic function abnormal,17001539
6,5,22.1,Malignant neoplasm progression,17001539
7,6,22.1,Dehydration,17001539
8,6,22.1,Hyponatraemia,17001539
0,3,22.1,Thrombosis,17001540
1,6,22.1,Peripheral swelling,17001540
2,5,22.1,Respiratory failure,17001540
0,6,22.1,Terminal state,17001546
0,6,22.1,Drug interaction,17001551
1,1,22.1,Headache,17001551
2,1,22.1,Visual impairment,17001551
3,1,22.1,Ataxia,17001551
4,1,22.1,Confusional state,17001551
5,1,22.1,Photophobia,17001551
6,1,22.1,Dyskinesia,17001551
7,1,22.1,Amnesia,17001551
8,1,22.1,Toxicity to various agents,17001551
0,5,22.1,Sepsis,17001555
0,5,22.1,Drug resistance,17001565
1,5,22.1,Metastases to lung,17001565
2,6,22.1,Metastases to liver,17001565
3,6,22.1,Malignant transformation,17001565
4,6,22.1,Neuroendocrine tumour of the lung,17001565
5,6,22.1,Metastases to pleura,17001565
6,6,22.1,Metastases to central nervous system,17001565
7,5,22.1,Pneumonia bacterial,17001565
8,6,22.1,Metastases to adrenals,17001565
9,6,22.1,Metastases to peritoneum,17001565
10,5,22.1,Malignant neoplasm progression,17001565
11,6,22.1,Metastases to lymph nodes,17001565
12,6,22.1,Metastases to heart,17001565
0,5,22.1,Sepsis,17001574
0,6,22.1,Device battery issue,17001640
0,3,22.1,Electrocardiogram T wave amplitude decreased,17001656
1,6,22.1,Electrocardiogram QRS complex shortened,17001656
2,3,22.1,Pleural effusion,17001656
3,5,22.1,Death,17001656
0,5,22.1,Cardiac failure,17001662
0,,22.1,Intercepted product preparation error,17001670
1,,22.1,Device leakage,17001670
2,,22.1,Wrong technique in product usage process,17001670
0,1,22.1,Vomiting,17001695
1,1,22.1,Neutropenic infection,17001695
2,1,22.1,Pulmonary embolism,17001695
3,1,22.1,Nausea,17001695
4,1,22.1,Candida infection,17001695
0,2,22.1,Nausea,17001696
1,2,22.1,Asthenia,17001696
2,2,22.1,Blood pressure increased,17001696
3,2,22.1,Tongue movement disturbance,17001696
4,2,22.1,Quadriplegia,17001696
5,2,22.1,Vomiting,17001696
0,5,22.1,Death,17001698
1,6,22.1,Neoplasm progression,17001698
0,,22.1,Intercepted product preparation error,17001707
1,,22.1,Device leakage,17001707
2,,22.1,Syringe issue,17001707
0,1,22.1,Dehydration,17001744
1,1,22.1,Acute kidney injury,17001744
2,1,22.1,Diarrhoea,17001744
0,3,22.1,Surgery,17001759
1,3,22.1,Sepsis,17001759
0,6,22.1,Drug resistance,17001763
1,6,22.1,Malignant transformation,17001763
2,6,22.1,Neuroendocrine tumour of the lung,17001763
0,6,22.1,Drug resistance,17001765
1,6,22.1,Neuroendocrine tumour of the lung,17001765
2,6,22.1,Malignant transformation,17001765
0,6,22.1,Neoplasm progression,17001798
0,1,22.1,Productive cough,17001802
1,1,22.1,Weight decreased,17001802
2,6,22.1,Off label use,17001802
3,1,22.1,Dysphagia,17001802
0,3,22.1,Fatigue,17001807
1,3,22.1,Myalgia,17001807
2,3,22.1,White blood cell count decreased,17001807
3,3,22.1,Neutrophil count decreased,17001807
0,6,22.1,Neuritis,17001817
1,6,22.1,Arthralgia,17001817
2,6,22.1,Platelet count decreased,17001817
3,6,22.1,Oedema peripheral,17001817
4,6,22.1,Muscle spasms,17001817
5,6,22.1,Arthritis,17001817
6,6,22.1,Feeling abnormal,17001817
7,6,22.1,Hot flush,17001817
8,6,22.1,Feeling of body temperature change,17001817
0,6,22.1,Blindness transient,17001826
1,6,22.1,Metastases to central nervous system,17001826
2,6,22.1,Product dose omission,17001826
0,6,22.1,Hair colour changes,17001827
1,6,22.1,Alopecia,17001827
2,6,22.1,Hair texture abnormal,17001827
3,6,22.1,Hair disorder,17001827
4,6,22.1,Madarosis,17001827
0,3,22.1,Wheelchair user,17001839
1,3,22.1,Cystitis,17001839
2,3,22.1,Cancer pain,17001839
3,3,22.1,Gait disturbance,17001839
4,3,22.1,Arterial disorder,17001839
0,3,22.1,Malignant neoplasm progression,17001860
0,1,22.1,Cholecystitis acute,17001896
0,6,22.1,Pruritus,17001902
0,6,22.1,Product use in unapproved indication,17001916
1,6,22.1,Neutropenia,17001916
0,6,22.1,Electrocardiogram abnormal,17002049
1,6,22.1,Nausea,17002049
2,6,22.1,Muscle spasms,17002049
3,1,22.1,Alopecia,17002049
4,6,22.1,Malaise,17002049
5,1,22.1,Weight decreased,17002049
6,6,22.1,Influenza,17002049
7,6,22.1,Ill-defined disorder,17002049
8,1,22.1,Rash,17002049
9,6,22.1,Fall,17002049
10,6,22.1,Depression,17002049
11,6,22.1,Pain,17002049
12,6,22.1,Neutrophil count decreased,17002049
0,1,22.1,Bone marrow failure,17002107
0,1,22.1,Bone marrow failure,17002115
1,6,22.1,Gastrointestinal disorder,17002115
0,6,22.1,Arthralgia,17002133
1,6,22.1,Adverse drug reaction,17002133
0,6,22.1,Rash,17002155
1,6,22.1,Diarrhoea,17002155
2,6,22.1,Malignant neoplasm progression,17002155
3,6,22.1,Lung disorder,17002155
4,6,22.1,Cerebral disorder,17002155
0,6,22.1,Malignant neoplasm progression,17002220
1,6,22.1,Ovarian cancer stage III,17002220
2,6,22.1,Product use in unapproved indication,17002220
3,6,22.1,Therapy non-responder,17002220
0,3,22.1,Enterocolitis,17002223
0,1,22.1,Otitis media,17002236
0,6,22.1,Anxiety,17002244
1,6,22.1,Acute kidney injury,17002244
2,6,22.1,Toxicity to various agents,17002244
3,6,22.1,Dizziness,17002244
4,6,22.1,Nausea,17002244
5,6,22.1,Oedema peripheral,17002244
6,6,22.1,Decreased appetite,17002244
7,6,22.1,Tremor,17002244
8,6,22.1,Syncope,17002244
9,6,22.1,Depression,17002244
10,6,22.1,Thrombocytopenia,17002244
11,6,22.1,Anaemia,17002244
12,6,22.1,Fatigue,17002244
13,6,22.1,Pneumonia,17002244
14,6,22.1,Stomatitis,17002244
15,6,22.1,Urinary tract infection,17002244
16,6,22.1,Drug intolerance,17002244
0,6,22.1,Malaise,17002259
1,6,22.1,Pain in extremity,17002259
2,6,22.1,Dysstasia,17002259
0,3,22.1,Investigation abnormal,17002261
0,2,22.1,Acute respiratory distress syndrome,17002264
1,6,22.1,Legionella infection,17002264
2,6,22.1,Product use in unapproved indication,17002264
3,2,22.1,Atypical pneumonia,17002264
0,4,22.1,Metastases to central nervous system,17002277
0,5,22.1,Septic shock,17002287
0,1,22.1,Pneumocystis jirovecii pneumonia,17002288
0,3,22.1,Dementia,17002293
0,6,22.1,Drug intolerance,17002304
1,6,22.1,White blood cell count decreased,17002304
2,6,22.1,Inappropriate schedule of product administration,17002304
3,6,22.1,General physical health deterioration,17002304
4,6,22.1,Blood glucose increased,17002304
5,6,22.1,Asthenia,17002304
6,6,22.1,Weight decreased,17002304
7,6,22.1,Vomiting,17002304
8,6,22.1,Decreased appetite,17002304
9,6,22.1,Haemoglobin decreased,17002304
0,6,22.1,Pancreatic carcinoma,17002305
0,6,22.1,Serum ferritin increased,17002306
1,6,22.1,Aspartate aminotransferase increased,17002306
2,6,22.1,Alanine aminotransferase increased,17002306
3,6,22.1,Gamma-glutamyltransferase increased,17002306
4,6,22.1,Hepatic steatosis,17002306
5,6,22.1,Glutamate dehydrogenase increased,17002306
6,6,22.1,Blood copper increased,17002306
7,2,22.1,Carpal tunnel syndrome,17002306
8,6,22.1,Hepatitis B surface antibody positive,17002306
0,6,22.1,Endometrial hypertrophy,17002322
1,6,22.1,Paget^s disease of nipple,17002322
2,6,22.1,Breast cancer recurrent,17002322
3,6,22.1,Menorrhagia,17002322
4,6,22.1,Weight increased,17002322
5,6,22.1,Arthralgia,17002322
0,5,22.1,Death,17002325
0,1,22.1,Cellulitis,17002327
1,1,22.1,Jugular vein embolism,17002327
0,1,22.1,Anaemia,17002333
1,1,22.1,Pyrexia,17002333
2,1,22.1,Myocardial necrosis marker increased,17002333
3,1,22.1,Febrile neutropenia,17002333
4,1,22.1,Thrombocytopenia,17002333
5,1,22.1,Diarrhoea,17002333
6,1,22.1,Mental status changes,17002333
7,1,22.1,Sepsis,17002333
8,1,22.1,Hypovolaemia,17002333
0,5,22.1,Death,17002356
0,5,22.1,Death,17002372
0,2,22.1,Loss of consciousness,17002402
1,1,22.1,Disseminated intravascular coagulation,17002402
2,6,22.1,Hypertensive encephalopathy,17002402
0,6,22.1,Malignant neoplasm progression,17002575
1,1,22.1,Neutropenia,17002575
2,1,22.1,Portal vein thrombosis,17002575
3,6,22.1,Dyspnoea,17002575
4,1,22.1,Leukopenia,17002575
5,1,22.1,Thrombocytopenia,17002575
0,6,22.1,Staphylococcal skin infection,17002636
0,5,22.1,Death,17002649
0,5,22.1,Death,17002650
0,6,22.1,Metastatic neoplasm,17002680
0,1,22.1,"Hallucination, auditory",17002683
1,2,22.1,Pneumonitis,17002683
2,6,22.1,Incontinence,17002683
3,1,22.1,Chills,17002683
4,3,22.1,Pulmonary fibrosis,17002683
5,1,22.1,Blood thyroid stimulating hormone increased,17002683
0,6,22.1,Ascites,17002684
1,6,22.1,Hypercholesterolaemia,17002684
2,6,22.1,Diabetes mellitus,17002684
0,1,22.1,Cytokine release syndrome,17002699
1,2,22.1,Neurotoxicity,17002699
2,6,22.1,Therapy non-responder,17002699
0,2,22.1,Hypoaesthesia,17002720
1,2,22.1,Suicide attempt,17002720
2,2,22.1,Fatigue,17002720
3,2,22.1,Taste disorder,17002720
0,1,22.1,Cerebral ischaemia,17002738
0,6,22.1,Urinary tract infection,17002744
1,6,22.1,Cataract,17002744
2,6,22.1,Urinary retention,17002744
3,2,22.1,Vulvovaginal mycotic infection,17002744
4,6,22.1,Alopecia,17002744
0,6,22.1,Pulmonary haemorrhage,17002769
0,6,22.1,Acute stress disorder,17002782
1,3,22.1,Diarrhoea,17002782
2,5,22.1,Coma,17002782
3,5,22.1,Acute respiratory distress syndrome,17002782
4,1,22.1,Intercostal neuralgia,17002782
5,5,22.1,Pneumocystis jirovecii infection,17002782
6,1,22.1,Chronic gastritis,17002782
7,1,22.1,Abdominal pain upper,17002782
8,1,22.1,Metastases to liver,17002782
9,1,22.1,Malignant neoplasm progression,17002782
10,5,22.1,Lung disorder,17002782
11,3,22.1,Fatigue,17002782
12,3,22.1,Nausea,17002782
13,1,22.1,Thoracic vertebral fracture,17002782
14,1,22.1,Intervertebral disc protrusion,17002782
15,1,22.1,Vomiting,17002782
16,1,22.1,Spinal stenosis,17002782
0,6,22.1,General physical health deterioration,17002846
0,1,22.1,Colitis,17002910
1,1,22.1,Acute kidney injury,17002910
0,2,22.1,Ejection fraction decreased,17002917
1,2,22.1,Hypotension,17002917
2,2,22.1,Troponin I increased,17002917
3,2,22.1,Myocarditis,17002917
0,3,22.1,Congestive cardiomyopathy,17002918
0,6,22.1,Atrial flutter,17002934
0,6,22.1,Atrial fibrillation,17002961
1,6,22.1,Bundle branch block left,17002961
0,1,22.1,Gallbladder disorder,17002966
1,1,22.1,Nephrolithiasis,17002966
2,1,22.1,Product dose omission,17002966
0,1,22.1,Muscle spasms,17002984
1,1,22.1,Paraesthesia,17002984
2,1,22.1,Hyperhidrosis,17002984
3,1,22.1,Dyspnoea,17002984
4,1,22.1,Vision blurred,17002984
0,1,22.1,Palatal oedema,17002992
0,2,22.1,Alopecia,17003001
1,2,22.1,Neutropenia,17003001
2,2,22.1,Leukopenia,17003001
3,2,22.1,Thrombocytopenia,17003001
0,3,22.1,Vascular purpura,17003072
0,6,22.1,Mucosal inflammation,17003112
0,5,22.1,Death,17003145
0,2,22.1,Conjunctivitis,17003303
0,3,22.1,Decreased appetite,17003368
1,3,22.1,Vision blurred,17003368
2,3,22.1,Diarrhoea,17003368
3,3,22.1,Dysphonia,17003368
4,3,22.1,Weight decreased,17003368
5,3,22.1,Constipation,17003368
6,3,22.1,Depression,17003368
7,3,22.1,Fatigue,17003368
0,5,22.1,Hepatic failure,17003371
0,6,22.1,Small intestinal obstruction,17003437
1,6,22.1,Dyspnoea,17003437
2,6,22.1,Urinary tract infection,17003437
0,6,22.1,Rash,17003506
0,6,22.1,Rash,17003509
0,6,22.1,Rash,17003511
0,6,22.1,Arthralgia,17003514
0,6,22.1,Clostridium difficile infection,17003544
1,1,22.1,Neutropenic sepsis,17003544
0,1,22.1,Abdominal pain upper,17003601
1,6,22.1,Therapeutic response unexpected,17003601
2,1,22.1,Saliva altered,17003601
3,6,22.1,Multiple sclerosis relapse,17003601
4,1,22.1,Gingival pain,17003601
5,1,22.1,Epistaxis,17003601
6,1,22.1,Adverse drug reaction,17003601
7,1,22.1,Rash,17003601
8,1,22.1,Hyperaesthesia teeth,17003601
9,3,22.1,Constipation,17003601
10,6,22.1,Urinary tract infection,17003601
11,1,22.1,Fatigue,17003601
12,6,22.1,Inappropriate schedule of product administration,17003601
13,1,22.1,Thrombocytopenia,17003601
14,1,22.1,Taste disorder,17003601
15,3,22.1,Asthenia,17003601
16,1,22.1,Dry mouth,17003601
17,1,22.1,Headache,17003601
0,1,22.1,Platelet count decreased,17003602
1,6,22.1,Product use issue,17003602
0,2,22.1,Fatigue,17003609
1,2,22.1,Nausea,17003609
2,6,22.1,Influenza,17003609
3,1,22.1,Renal impairment,17003609
4,6,22.1,Product dose omission,17003609
5,6,22.1,Underdose,17003609
0,6,22.1,Disease progression,17003617
1,1,22.1,Paraesthesia,17003617
2,6,22.1,Eye operation,17003617
3,6,22.1,Abdominal pain upper,17003617
4,1,22.1,Decreased appetite,17003617
5,1,22.1,Nausea,17003617
6,2,22.1,Anxiety,17003617
7,6,22.1,Headache,17003617
8,6,22.1,Pain,17003617
9,6,22.1,Pruritus,17003617
10,6,22.1,Pneumonia,17003617
11,6,22.1,Recurrent cancer,17003617
12,1,22.1,Taste disorder,17003617
13,1,22.1,Constipation,17003617
14,6,22.1,Tumour marker increased,17003617
15,2,22.1,Depression,17003617
16,1,22.1,Weight decreased,17003617
17,1,22.1,Dizziness,17003617
18,1,22.1,Vomiting,17003617
19,1,22.1,Dehydration,17003617
20,1,22.1,Asthenopia,17003617
21,1,22.1,Dermatitis acneiform,17003617
22,1,22.1,Insomnia,17003617
23,1,22.1,Fatigue,17003617
24,6,22.1,Drug ineffective,17003617
0,2,22.1,Atypical haemolytic uraemic syndrome,17003646
0,3,22.1,Left ventricular dysfunction,17003754
0,6,22.1,Femur fracture,17003813
0,6,22.1,Neutropenia,17003824
1,6,22.1,Nephropathy toxic,17003824
0,6,22.1,Stomatitis,17003830
1,6,22.1,Product use in unapproved indication,17003830
2,6,22.1,Speech disorder,17003830
0,5,22.1,Febrile neutropenia,17003835
0,5,22.1,Febrile neutropenia,17003838
1,5,22.1,Neutropenic sepsis,17003838
0,1,22.1,Hepatic function abnormal,17003848
0,1,22.1,Duodenal ulcer perforation,17003858
1,1,22.1,Hypoxia,17003858
2,1,22.1,Dyspnoea,17003858
0,6,22.1,Pleurisy,17003875
0,6,22.1,Chloroma,17003876
1,6,22.1,Chest wall haematoma,17003876
0,1,22.1,Cystitis,17003879
0,1,22.1,Flushing,17003882
1,6,22.1,Product lot number issue,17003882
2,1,22.1,Chest discomfort,17003882
0,6,22.1,Anaemia,17003885
1,6,22.1,Toxicity to various agents,17003885
2,6,22.1,Fistula,17003885
3,6,22.1,Drug intolerance,17003885
0,6,22.1,Blister,17003891
1,6,22.1,Rash papular,17003891
2,6,22.1,Skin oedema,17003891
3,6,22.1,Erythema,17003891
0,6,22.1,Staphylococcal sepsis,17003893
1,6,22.1,Catheter site infection,17003893
2,6,22.1,Neoplasm progression,17003893
0,1,22.1,Clostridium difficile infection,17003900
1,1,22.1,Colitis microscopic,17003900
2,1,22.1,Diarrhoea,17003900
3,1,22.1,Febrile neutropenia,17003900
0,1,22.1,Radiation pneumonitis,17003927
0,1,22.1,Neutropenia,17003928
1,2,22.1,Pulmonary embolism,17003928
2,1,22.1,Granulocytopenia,17003928
3,1,22.1,Leukopenia,17003928
0,2,22.1,Biopsy lung abnormal,17003943
0,2,22.1,Bladder discomfort,17003991
1,4,22.1,Blood urine present,17003991
0,6,22.1,Disseminated Bacillus Calmette-Guerin infection,17004002
1,2,22.1,Pyelonephritis,17004002
2,6,22.1,Suprapubic pain,17004002
3,6,22.1,Abdominal pain lower,17004002
4,1,22.1,Pyrexia,17004002
5,6,22.1,Retinal vasculitis,17004002
6,1,22.1,Urinary retention,17004002
7,6,22.1,Chorioretinal disorder,17004002
8,6,22.1,Chills,17004002
9,6,22.1,Night sweats,17004002
0,6,22.1,Haemoglobin decreased,17004004
1,6,22.1,Decreased appetite,17004004
2,6,22.1,Platelet count decreased,17004004
3,6,22.1,White blood cell count decreased,17004004
4,6,22.1,Vomiting,17004004
5,6,22.1,Neutrophil count decreased,17004004
6,6,22.1,Nausea,17004004
7,6,22.1,Hyperkalaemia,17004004
8,6,22.1,Gamma-glutamyltransferase increased,17004004
9,6,22.1,Alanine aminotransferase increased,17004004
10,6,22.1,Aspartate aminotransferase increased,17004004
0,5,22.1,Myocardial infarction,17004020
0,6,22.1,Decreased appetite,17004034
1,6,22.1,Malnutrition,17004034
2,6,22.1,Dementia,17004034
3,6,22.1,Amnesia,17004034
0,2,22.1,Hypertriglyceridaemia,17004049
1,2,22.1,Pancreatitis,17004049
0,6,22.1,Pain of skin,17004102
1,6,22.1,Skin atrophy,17004102
2,3,22.1,Hyperaesthesia,17004102
0,1,22.1,Hypersensitivity pneumonitis,17004151
1,1,22.1,Dyspnoea,17004151
2,1,22.1,Oxygen saturation decreased,17004151
0,2,22.1,Bronchial polyp,17004154
1,2,22.1,Pulmonary oedema,17004154
2,2,22.1,Respiratory failure,17004154
3,2,22.1,Hypoxia,17004154
4,2,22.1,Computerised tomogram thorax abnormal,17004154
5,2,22.1,Therapeutic response decreased,17004154
6,2,22.1,Biopsy lung abnormal,17004154
7,2,22.1,Organising pneumonia,17004154
8,2,22.1,Multifocal micronodular pneumocyte hyperplasia,17004154
0,1,22.1,Product dose omission,17004155
1,1,22.1,Rash,17004155
2,1,22.1,Urticaria,17004155
0,6,22.1,Dizziness,17004157
1,6,22.1,Influenza like illness,17004157
2,6,22.1,Vomiting,17004157
3,6,22.1,Unresponsive to stimuli,17004157
4,6,22.1,White blood cell count abnormal,17004157
5,6,22.1,Blood potassium decreased,17004157
6,6,22.1,Diarrhoea,17004157
7,6,22.1,Hypotension,17004157
0,6,22.1,White blood cell count abnormal,17004194
1,6,22.1,Vomiting,17004194
2,6,22.1,Hypotension,17004194
3,6,22.1,Diarrhoea,17004194
4,6,22.1,Blood potassium decreased,17004194
5,6,22.1,Dizziness,17004194
6,6,22.1,Influenza like illness,17004194
7,6,22.1,Unresponsive to stimuli,17004194
0,1,22.1,Pneumonia,17004195
0,6,22.1,Neutropenic sepsis,17004214
1,6,22.1,Atrial fibrillation,17004214
2,3,22.1,Type 2 diabetes mellitus,17004214
3,6,22.1,Diabetic ketoacidosis,17004214
4,6,22.1,Glycosylated haemoglobin increased,17004214
0,3,22.1,Malaise,17004223
0,1,22.1,Pulmonary embolism,17004261
0,1,22.1,Colitis,17004271
1,1,22.1,Acute kidney injury,17004271
0,1,22.1,Neutropenia,17004292
1,6,22.1,Neoplasm progression,17004292
2,6,22.1,Pancytopenia,17004292
0,6,22.1,Neoplasm progression,17004293
1,6,22.1,Cancer pain,17004293
2,6,22.1,Pancytopenia,17004293
3,6,22.1,Anaemia,17004293
4,6,22.1,Nausea,17004293
0,1,22.1,Interstitial lung disease,17004304
0,2,22.1,Myocardial infarction,17004305
0,2,22.1,Cholangitis,17004308
1,6,22.1,Colitis,17004308
0,3,22.1,Inflammation,17004341
1,6,22.1,Gingival hypertrophy,17004341
2,6,22.1,Furuncle,17004341
3,1,22.1,Oral mucosal exfoliation,17004341
4,6,22.1,Pain,17004341
5,6,22.1,Pruritus,17004341
6,6,22.1,Cellulitis,17004341
7,6,22.1,Headache,17004341
8,6,22.1,Hordeolum,17004341
9,6,22.1,Skin exfoliation,17004341
10,6,22.1,Decreased appetite,17004341
11,6,22.1,Rash,17004341
12,6,22.1,Decreased immune responsiveness,17004341
13,6,22.1,Pharyngeal disorder,17004341
14,6,22.1,Viral infection,17004341
15,6,22.1,Eye pain,17004341
16,6,22.1,Oral discomfort,17004341
17,6,22.1,Haemoglobin decreased,17004341
18,6,22.1,Diarrhoea,17004341
19,1,22.1,Flavivirus infection,17004341
20,6,22.1,Malaise,17004341
21,1,22.1,Influenza,17004341
22,6,22.1,Bone pain,17004341
23,6,22.1,Musculoskeletal pain,17004341
24,6,22.1,Mood altered,17004341
25,6,22.1,Hypersensitivity,17004341
26,6,22.1,Swelling,17004341
27,6,22.1,Pain in extremity,17004341
28,6,22.1,Weight decreased,17004341
29,6,22.1,Chikungunya virus infection,17004341
30,3,22.1,Dry skin,17004341
0,1,22.1,Product lot number issue,17004345
1,1,22.1,Therapy cessation,17004345
2,1,22.1,Infusion related reaction,17004345
0,6,22.1,Confusional state,17004359
1,6,22.1,Limb injury,17004359
2,5,22.1,Respiratory failure,17004359
3,3,22.1,Pneumonia,17004359
4,6,22.1,Nasopharyngitis,17004359
0,1,22.1,Cutaneous vasculitis,17004374
1,6,22.1,Subdural haematoma,17004374
0,6,22.1,Malignant neoplasm progression,17004391
1,6,22.1,Drug resistance,17004391
0,3,22.1,Dry eye,17004396
1,3,22.1,Periorbital oedema,17004396
2,3,22.1,Mucosal inflammation,17004396
0,5,22.1,Death,17004402
0,3,22.1,Blood testosterone abnormal,17004403
0,6,22.1,Spinal fracture,17004404
1,6,22.1,Arthralgia,17004404
0,6,22.1,Hip fracture,17004409
0,6,22.1,Bundle branch block left,17004425
1,6,22.1,Atrial fibrillation,17004425
0,3,22.1,Cardiac dysfunction,17004426
1,2,22.1,Cardiac failure,17004426
2,2,22.1,Dyspnoea,17004426
0,6,22.1,Erythema,17004427
0,6,22.1,Hypertension,17004431
1,5,22.1,Malignant neoplasm progression,17004431
2,6,22.1,Proteinuria,17004431
0,3,22.1,Cerebrovascular accident,17004455
1,6,22.1,Haemoglobin decreased,17004455
2,6,22.1,Asthenia,17004455
3,1,22.1,Tooth infection,17004455
4,1,22.1,Hypertension,17004455
5,6,22.1,Diarrhoea,17004455
0,6,22.1,Malaise,17004456
1,5,22.1,Death,17004456
0,3,22.1,Hair texture abnormal,17004466
1,3,22.1,Hair disorder,17004466
2,3,22.1,Madarosis,17004466
3,3,22.1,Alopecia,17004466
4,3,22.1,Hair colour changes,17004466
0,1,22.1,Malaise,17004495
0,6,22.1,Nodule,17004496
0,6,22.1,Sinus congestion,17004498
1,1,22.1,Chest pain,17004498
2,1,22.1,Musculoskeletal stiffness,17004498
3,6,22.1,Head injury,17004498
4,6,22.1,Sleep disorder,17004498
5,6,22.1,Night sweats,17004498
6,1,22.1,Constipation,17004498
7,6,22.1,Balance disorder,17004498
8,6,22.1,Depression,17004498
9,6,22.1,Dyspnoea,17004498
10,6,22.1,Nervousness,17004498
11,6,22.1,Fatigue,17004498
12,1,22.1,Diarrhoea,17004498
13,6,22.1,White blood cell count abnormal,17004498
14,6,22.1,Neutropenia,17004498
15,6,22.1,Haemorrhagic diathesis,17004498
16,6,22.1,Myalgia,17004498
17,6,22.1,Headache,17004498
18,6,22.1,Depressed mood,17004498
19,1,22.1,Abdominal pain,17004498
20,6,22.1,Dizziness,17004498
21,3,22.1,Blood count abnormal,17004498
22,1,22.1,Chest discomfort,17004498
23,6,22.1,Anxiety,17004498
0,6,22.1,Product dose omission,17004499
1,2,22.1,Cough,17004499
2,1,22.1,White blood cell count decreased,17004499
0,6,22.1,White blood cell disorder,17004507
0,6,22.1,Nausea,17004524
0,3,22.1,Thrombocytopenia,17004537
1,6,22.1,Alopecia,17004537
2,6,22.1,Fatigue,17004537
3,6,22.1,Hot flush,17004537
4,3,22.1,Neutropenia,17004537
5,6,22.1,White blood cell count decreased,17004537
0,3,22.1,Pneumonitis,17004538
0,6,22.1,Fatigue,17004543
1,6,22.1,Neutrophil count decreased,17004543
2,6,22.1,Decreased appetite,17004543
0,6,22.1,Chronic kidney disease,17004545
1,6,22.1,Bone marrow disorder,17004545
0,6,22.1,Neoplasm progression,17004546
0,6,22.1,Neoplasm progression,17004547
0,6,22.1,Alopecia,17004559
0,6,22.1,Off label use,17004561
1,6,22.1,Product use in unapproved indication,17004561
2,6,22.1,Neoplasm progression,17004561
0,3,22.1,Hair texture abnormal,17004564
1,3,22.1,Alopecia,17004564
2,3,22.1,Madarosis,17004564
3,3,22.1,Hair disorder,17004564
4,3,22.1,Hair colour changes,17004564
0,6,22.1,Neoplasm progression,17004565
0,6,22.1,Malaise,17004567
0,6,22.1,Myocardial infarction,17004576
1,6,22.1,Paronychia,17004576
2,6,22.1,Peripheral artery thrombosis,17004576
3,6,22.1,Peripheral artery thrombosis,17004576
4,6,22.1,Cardiac failure congestive,17004576
5,6,22.1,Ulcer,17004576
0,6,22.1,Choking,17004590
1,6,22.1,Product dose omission,17004590
2,6,22.1,Product use complaint,17004590
3,6,22.1,Product size issue,17004590
4,5,22.1,Death,17004590
0,3,22.1,Renal failure,17004600
1,3,22.1,White blood cell count decreased,17004600
2,3,22.1,Neoplasm progression,17004600
3,3,22.1,Haemoglobin decreased,17004600
4,1,22.1,Sepsis,17004600
0,6,22.1,Back pain,17004609
1,6,22.1,Influenza,17004609
2,6,22.1,Catheter site pain,17004609
3,6,22.1,Hepatomegaly,17004609
4,6,22.1,Dyspnoea,17004609
0,6,22.1,Fatigue,17004611
0,6,22.1,Burning sensation,17004613
1,6,22.1,Haemoglobin decreased,17004613
2,6,22.1,Dry skin,17004613
3,6,22.1,Asthenia,17004613
